Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Oxford Health Plan (OXHP) -- Ignore unavailable to you. Want to Upgrade?

To: Thomas Haegin who wrote (1015)	2/11/1998 7:33:00 AM
From: DRRISK	Read Replies (1) \| Respond to of 2068

Hi Tom, I am playing this baby because they are taking out Wiggens and putting in a Dr. This is a rough play but Price is always right when he makes a move like this. Have a history with him and this is going to humm. The short term could be bumpy though. Hope not. The piece in the WSJ this AM was totally cryptic and it seems that everyone wants a piece of this company. The indication is that we have a play here. I think sooner then later for sure before earnings because this puppy needs a doctor in a hurry. DrRisk

To: Thomas Haegin who wrote (1015)	2/11/1998 7:37:00 AM
From: Premier	Read Replies (1) \| Respond to of 2068

Thomas: DLJ unit has advanced 100MM and Oxford has option to borrow another $100MM. This helps in immediate liquidity problem. KKR/Texas Pacific are in talks so is Insurance Partners for permanent financing of 200MM to 500MM. The financing could come in the form of debt, equity or convertibles. No deal is imminent at this time. KKR seems to favor Payson. The financing in whatever form it comes will have negative effect on stock. KKR type partners will have positive impact on the stock. Your approach of waiting till quarterly EPS before making additional commitment is preferable. IMHO,in the long run the stock will be at higher levels from here and in the short term it will remain highly volatile. Premier

To: Thomas Haegin who wrote (1015)	2/11/1998 8:43:00 AM
From: Thomas Haegin	Respond to of 2068

Premier and all, thought you might like to see a repost the Reuters newsclip on the $100m bridge loan. Really just FYI: ---------------------- Oxford gets $100 mln loan from DLJ unit-WSJ Reuters Story - February 11, 1998 03:39 ÿÿÿÿ NEW YORK, Feb 11 (Reuters) - Oxford Health Plans Inc has obtained a $100 million loan from a unit of Donaldson Lufkin & Jenrette , the Wall Street Journal said Wednesday in its electronic edition. ÿÿÿÿ Meanwhile, Texas Pacific Group and Kohlberg Kravis Roberts & Co are among companies discussing making an equity investment in Oxford, the Journal said. ÿÿÿÿ In a filing with the Securities and Exchange Commission late Tuesday, Oxford said the money is intended to be a bridge loan pending its ability to secure additional financing sometime this year, the Journal reported. ÿÿÿÿ The filing also says the company has the option of securing another $100 million from DLJ if needed to satisfy regulatory requirements and for general corporate purposes, the according to the Journal. ÿÿÿ In addition, the Journal reported that Texas Pacific and KKR are considering whether to make a joint investment in the company. ÿÿÿ Citing people familiar with the situation, the newspaper said the two buyout firms are believed to be backing Norman Payson, former chief executive of Healthsource Inc , as Oxford's CEO. ÿÿ No transaction is believed imminent, the Journal said. ÿÿ Representatives of the two buyout firms wouldn't comment; Oxford confirmed the DLJ financing but wouldn't comment further, the newspaper said. ÿÿÿ Also, the Journal reported that a group that includes Insurance Partners L.P., a New York investment fund specialising in insurance, is also scrutinising Oxford's books and talking with the company about a pact. ÿÿÿ Representatives of the fund wouldn't comment, the Journal said. ÿÿÿ Oxford is seeking financing that could range from $200 million to $500 million and come in the form of equity, debt or possibly a convertible stock offering, the newspaper said. ----------End---------